Jennifer Kyle, CEO and founder of Condor, discusses the inspiration behind creating a financial cloud platform specifically ...

Under terms of the deal, Merck will gain global rights to develop, manufacture, and commercialize HRS-5346 for cardiovascular ...

Under terms of the license agreement, Novo Nordisk will acquire the rights to develop and commercialize UBT251 outside of ...

Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, discusses ethical considerations ...

Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy ...

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine. Anixa Biosciences, Inc. March 24, 2025.

Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, addresses patient and prescriber ...

The facility, which is set to open amid Biogen’s 50th anniversary, will integrate research and development, technical ...

The test works by looking for cell-free nucleosomes in the blood. The study included 229 patients diagnosed with cancer and ...

Peter Ax, Founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry, and how digital ...

The investment, which is a 25% increase from previous years, will support three new advanced manufacturing facilities, ...

The FDA has approved Novartis’ Fabhalta (iptacopan) as the first and only treatment for C3 glomerulopathy (C3G). Previously, patients with C3G were forced to rely on supportive care and broad ...